Current through Rules and Regulations filed through March 20, 2024
(1) Effective October 6, 2014, Official Code
of Georgia Annotated (O.C.G.A.) §§
16-13-27(4)(C), 16-13-27(4)(D)
are hereby removed from Schedule III of the Georgia Controlled Substances Act,
O.C.G.A.
16-13-25, et. seq. The following language shall be deleted from O.C.G.A. §§
16-13-27(4):
"(C) Not more than 300 milligrams of dihydrocodeinone (hydrocodone), or any of
its salts, per 100 milliliters or not more than 15 milligrams per dosage unit,
with a fourfold or greater quantity of an isoquinoline alkaloid of opium; (D)
Not more than 300 milligrams of dihydrocodeinone (hydrocodone), or any of its
salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized therapeutic
amounts."
(2) Effective October 6,
2014, all Hydrocodone Combination Products (HCPs) in the State of Georgia are
Schedule II controlled substances.
(a) Each
registrant possessing HCPs must make an actual count inventory of all HCPs as
of October 6, 2014 and maintain it with the registrant's biennial DEA
inventory.
(b) All HCPs products
must be treated as any other Schedule II controlled substance. There can be no
oral prescriptions except in the case of an emergency, and all hard-copy HCP
prescriptions must be issued on security paper.
(c) For any HCP prescription written and
filled before October 6, 2014 with authorized refills, the prescription can be
refilled only for the authorized number of refills prior to April 8,
2015.
(3) This rule is
based on the following findings of the Board:
(a) that as Schedule III controlled
substances, HCPs have an extremely high potential for abuse;
(b) that scientific evidence and scientific
knowledge of the pharmacological effects of HCPs demonstrate that the public is
at extreme risk if HCPs are not regulated as Schedule II controlled
substances;
(c) that the history
and pattern of abuse of HCPs as a Schedule III controlled substance and the
scope and significance of that abuse support stricter regulation;
(d) that as a Schedule III controlled
substance, there exists an imminent peril to the public health and welfare with
regard to the abuse of HCPs;
(e)
that HCPs have the same risk to the public health of citizens of the State of
Georgia as other Schedule II controlled substances already contained in the
Georgia Controlled Substances Act;
(f) that as of October 6, 2014, the U.S. Drug
Enforcement Administration has removed all reference to HCPs from Schedule III
of 21 CFR 1308.13, which places all HCPs under Schedule II of
21 CFR 1308.12.
O.C.G.A. §§
16-13-22, 26-4-28, and
50-13-4.
